|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 17/09/14 | CHUGAI PHARMACEUTICAL : Roche's $8 billion InterMune buy not a signal for more big deals | RE |
| 04/09/14 | Roche : rules out mega deals, open to smaller ones - paper | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Thompson
CEO | Chief Executive Officer | 57 | - |
| Chief Tech/Sci/R&D Officer | 71 | 01/04/2002 | |
Carla Fiankan
LAW | General Counsel | - | 01/08/2011 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +4.16% | +3.04% | +49.37% | +94.17% | 74.41B | ||
| -1.26% | -1.68% | +24.25% | +77.94% | 59.26B | ||
| +1.36% | -0.46% | +4.46% | +34.74% | 47.14B | ||
| -3.02% | -5.20% | +27.94% | +32.51% | 42.91B | ||
| +0.31% | +3.02% | +348.95% | +643.82% | 44.13B | ||
| -1.96% | -0.33% | +7.04% | +99.46% | 40.79B | ||
| +3.32% | +3.49% | +10.10% | +51.23% | 30.77B | ||
| -2.68% | +2.92% | +29.63% | +22.72% | 29.31B | ||
| -4.86% | -10.66% | -26.27% | +330.06% | 23.71B | ||
| Average | -0.51% | -0.52% | +52.83% | +154.07% | 43.6B | |
| Weighted average by Cap. | +0.03% | -0.32% | +58.00% | +145.75% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
















